Atlas Trials

Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-Spheres

Clinical trial NCT04903548 · COMPLETED

Trial details

NCT number
NCT04903548
Sponsor
Methodist Health System
Status
COMPLETED
Study type
OBSERVATIONAL
Hepatocellular Carcinoma
Start date
2021-01-08
Primary completion
2024-10-18
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.